Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Elming

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|August 29, 2018
Partial Oral versus Intravenous Antibiotic Treatment of EndocarditisKasper Iversen, Nikolaj Ihlemann, Sabine U Gill, et al.
The American Journal of Cardiology|May 4, 2024
Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment TrialRasmus Carter-Storch, Mia Marie Pries-Heje, Jonas A Povlsen, et al.
Heart (British Cardiac Society)|October 6, 2021
Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditisMia Marie Pries-Heje, Rasmus Bo Hasselbalch, Christoffer Wiingaard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2022
Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2025
Target attainment of benzylpenicillin in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
The New England Journal of Medicine|February 9, 2022
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) TrialMia M Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2023
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Franziska Schwartz, et al.
Journal of Psychosomatic Research|January 25, 2022
The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2023
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET SubstudyMagnus Bock, Anna Marie Theut, Johan G C van Hasselt, et al.
Circulation|December 20, 2018
Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary SyndromeKlaus F Kofoed, Henning Kelbæk, Peter Riis Hansen, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|August 29, 2018
Partial Oral versus Intravenous Antibiotic Treatment of EndocarditisKasper Iversen, Nikolaj Ihlemann, Sabine U Gill, et al.
The American Journal of Cardiology|May 4, 2024
Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment TrialRasmus Carter-Storch, Mia Marie Pries-Heje, Jonas A Povlsen, et al.
Heart (British Cardiac Society)|October 6, 2021
Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditisMia Marie Pries-Heje, Rasmus Bo Hasselbalch, Christoffer Wiingaard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2022
Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2025
Target attainment of benzylpenicillin in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Kurt Fuursted, et al.
The New England Journal of Medicine|February 9, 2022
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) TrialMia M Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2023
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditisMagnus Bock, Johan G C Van Hasselt, Franziska Schwartz, et al.
Journal of Psychosomatic Research|January 25, 2022
The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trialJohan S Bundgaard, Kasper Iversen, Mia Pries-Heje, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2023
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET SubstudyMagnus Bock, Anna Marie Theut, Johan G C van Hasselt, et al.
Circulation|December 20, 2018
Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary SyndromeKlaus F Kofoed, Henning Kelbæk, Peter Riis Hansen, et al.
Pageof 5